GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UCB SA (LTS:0NZT) » Definitions » Cyclically Adjusted PB Ratio

UCB (LTS:0NZT) Cyclically Adjusted PB Ratio : 3.00 (As of May. 21, 2024)


View and export this data going back to 2009. Start your Free Trial

What is UCB Cyclically Adjusted PB Ratio?

As of today (2024-05-21), UCB's current share price is €126.35. UCB's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was €42.12. UCB's Cyclically Adjusted PB Ratio for today is 3.00.

The historical rank and industry rank for UCB's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0NZT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.87   Med: 1.81   Max: 3.3
Current: 2.95

During the past 13 years, UCB's highest Cyclically Adjusted PB Ratio was 3.30. The lowest was 0.87. And the median was 1.81.

LTS:0NZT's Cyclically Adjusted PB Ratio is ranked worse than
64.81% of 648 companies
in the Biotechnology industry
Industry Median: 1.745 vs LTS:0NZT: 2.95

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

UCB's adjusted book value per share data of for the fiscal year that ended in Dec23 was €47.292. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €42.12 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


UCB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for UCB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UCB Cyclically Adjusted PB Ratio Chart

UCB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.92 2.41 2.86 1.83 1.87

UCB Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.86 - 1.83 - 1.87

Competitive Comparison of UCB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, UCB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UCB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, UCB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where UCB's Cyclically Adjusted PB Ratio falls into.



UCB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

UCB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=126.35/42.12
=3.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UCB's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, UCB's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=47.292/128.2922*128.2922
=47.292

Current CPI (Dec23) = 128.2922.

UCB Annual Data

Book Value per Share CPI Adj_Book
201412 26.184 99.086 33.902
201512 30.129 100.572 38.433
201612 29.596 102.614 37.002
201712 30.886 104.804 37.808
201812 33.403 107.252 39.956
201912 37.326 108.065 44.313
202012 38.466 108.511 45.478
202112 44.330 114.705 49.581
202212 47.807 126.578 48.455
202312 47.292 128.292 47.292

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


UCB  (LTS:0NZT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


UCB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of UCB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


UCB (LTS:0NZT) Business Description

Industry
Address
Allee de la Recherche, 60, Brussels, BEL, B-1070
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), and Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome).

UCB (LTS:0NZT) Headlines

No Headlines